Drug Profile
Somatropin biosimilar - Biosidus
Alternative Names: Growmax™; HHT; SomatropLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biosidus S.A.
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Somatotropin deficiency
Most Recent Events
- 14 May 2012 Launched for Somatotropin deficiency in Brazil (SC)
- 10 Aug 2011 Launched for Somatotropin deficiency in Argentina (SC)
- 17 May 2011 Launched for Somatotropin deficiency in Chile (SC)